You're viewing a free preview.You're viewing a free preview — a sample of each dataset.

Funding Tracker

Every disclosed longevity round — size, stage and the investors behind it.

174 funding rounds tracked

Company	Amount	Round	Investors	Date
Vanta Holdings Inc.	CA$124,579.42	Private Placement	—	08/21/26
Longevium	$7M	Seed	—	08/03/26
Sonata	$7M	Seed	Lux Capital; BoxGroup; Sunflower Capital	07/19/26
Neko Health	$700M	Series C	Lightspeed Venture Partners (lead), O.G. Venture Partners (co-lead), Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, BDT & MSD	07/15/26
ARTAN Bio	$1M	Seed	Michael Torres (co-founder)	07/01/26
Rem3dy Health	£14m	Series A	not stated	06/28/26
Rapalogix Health	$20M	Series A	not stated	06/23/26
Oligomerix	$1.9M	Grant	NIH	06/19/26
COUR Pharmaceuticals	$50M	Series B	Lumira Ventures, Roche Venture Fund, Sanofi, Alpha Wave Ventures, Pfizer Ventures, Angelini Ventures, T1D Fund	06/18/26
June Health	CAD$2.4M	Seed	not stated	06/18/26

Showing 10 of 174 funding rounds

Peek at other modules

Curated longevity industry headlines with AI summaries, updated continuously.

The longevity company universe by segment, stage, geography and capital raised.

Longevity-relevant trials by phase, sponsor, status and indication.

Who is joining, leaving and founding across the longevity sector.

Peer-reviewed aging research distilled into investor-relevant takeaways.

FDA, EMA and policy developments that move the longevity market.